Peer Reviewed Publication , Modified Release

Scientific Paper_ Development of a Prototype, Once-Daily, Modified Release Formulation for the Short Half-Life RIPK1 Inhibitor GSK2982772

1 February 2021
  • Home
  • Resources
  • Scientific Paper_ Development of a Prototype, Once-Daily, Modified Release Formulation for the Short Half-Life RIPK1 Inhibitor GSK2982772
Overview

ABSTRACT
Purpose GSK2982772 is a selective inhibitor of receptor interacting protein kinase-1, with a 2–3 h half-life. This study
evaluated if a once-daily modified-release formulation of
GSK2982772 could be developed with no significant food
effect

Download
Date
1 February 2021